<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">639</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2022-21-4-134-141</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">A familial case of <italic>DICER1</italic> syndrome in a patient with pleuropulmonary blastoma</article-title><trans-title-group xml:lang="ru"><trans-title>Семейный случай <italic>DICER1</italic>-синдрома у пациента с плевропульмональной бластомой</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4042-0125</contrib-id><name-alternatives><name xml:lang="en"><surname>Teleshova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Телешова</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>a pediatric oncologist of the Department of Clinical Oncology</p></bio><bio xml:lang="ru"><p>врач-детский онколог отделения клинической онкологии</p></bio><email>teleshova_m@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3007-3772</contrib-id><name-alternatives><name xml:lang="en"><surname>Yasko</surname><given-names>L. A.</given-names></name><name xml:lang="ru"><surname>Ясько</surname><given-names>Л. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><email>teleshova_m@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6818-4027</contrib-id><name-alternatives><name xml:lang="en"><surname>Maslenkova</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Маслёнкова</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><email>teleshova_m@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0404-6420</contrib-id><name-alternatives><name xml:lang="en"><surname>Merkulov</surname><given-names>N. N.</given-names></name><name xml:lang="ru"><surname>Меркулов</surname><given-names>Н. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><email>teleshova_m@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7732-8184</contrib-id><name-alternatives><name xml:lang="en"><surname>Konovalov</surname><given-names>D. M.</given-names></name><name xml:lang="ru"><surname>Коновалов</surname><given-names>Д. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><email>teleshova_m@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0900-6874</contrib-id><name-alternatives><name xml:lang="en"><surname>Kurnikova</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Курникова</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><email>teleshova_m@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Doronina</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Доронина</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Murmansk</italic></p></bio><bio xml:lang="ru"><p><italic>Мурманск</italic></p></bio><email>teleshova_m@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3767-4477</contrib-id><name-alternatives><name xml:lang="en"><surname>Shamanskaya</surname><given-names>T. V.</given-names></name><name xml:lang="ru"><surname>Шаманская</surname><given-names>Т. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><email>teleshova_m@mail.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3704-8783</contrib-id><name-alternatives><name xml:lang="en"><surname>Kachanov</surname><given-names>D. Yu.</given-names></name><name xml:lang="ru"><surname>Качанов</surname><given-names>Д. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии имени Дмитрия Рогачева</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Murmansk Regional Children's Clinical Hospital</institution></aff><aff><institution xml:lang="ru">ГОБУЗ «Мурманская областная детская клиническая больница»</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-12-26" publication-format="electronic"><day>26</day><month>12</month><year>2022</year></pub-date><volume>21</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>134</fpage><lpage>141</lpage><history><date date-type="received" iso-8601-date="2022-07-27"><day>27</day><month>07</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-09-07"><day>07</day><month>09</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/639">https://hemoncim.com/jour/article/view/639</self-uri><abstract xml:lang="en"><p>Pleuropulmonary blastoma (PPB) is a very rare tumor of childhood that arises from the mesenchyme of the lung and is associated with mutations in the DICER1 gene. The present article describes a familial case of DICER1 syndrome in a patient aged 3 years and 11 months who underwent investigations and treatment for type II/III PPB of the lower lobe of the left lung at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. The patient's parents gave their consent to the use of their child's data, including photographs, for research purposes and in publications. The diagnosis was made based on the results of the pathology investigation of the tissue obtained by open biopsy. Furthermore, the diagnosis was confirmed by the review of histological specimens in the International PPB Registry (Minneapolis, USA). According to the data from the chest CT with intravenous contrast enhancement, the tumor was described as a mass consisting of cystic cavities of various calibers accumulating a contrast agent along the periphery, and a solid component. Specific combination treatment was based on the recommendations of the International PPB Registry and included chemotherapy according to the IVADo/IVA regimen and surgical treatment as a local control. Currently, specific treatment has been completed, the patient is alive with no signs of the disease, the follow-up period was 20 months. As regards the patient's family history, he has a sibling (older brother) who was diagnosed with a cystic nephroma at the age of 1 year and 4 months. Molecular genetic testing of the tumor tissues obtained from the patient (PPB) and his sibling (cystic nephroma) revealed pathogenic somatic variants in the DICER1 gene. Along with the somatic genetic variants, another pathogenic variant was found in both children, the germline status of which was confirmed. The germline variant in the DICER1 gene was inherited from the mother. Thus, the investigations confirmed a familial case of DICER1 syndrome. The case described in this article indicates that families in which DICER1 syndrome was found require special management aimed at early detection of tumors and non-tumor conditions associated with this syndrome in the carriers of pathogenic alleles.</p></abstract><trans-abstract xml:lang="ru"><p>Плевропульмональная бластома (ППБ) – очень редкая опухоль детского возраста, развивающаяся из легочной мезенхимы и ассоциированная с мутациями в гене DICER1. В работе описан случай семейной формы DICER1-синдрома на примере пациента 3 лет 11 месяцев, проходившего обследование и лечение в НМИЦ ДГОИ им. Дмитрия Рогачева по поводу ППБ II/III типа нижней доли левого легкого. Родители пациента дали согласие на использование информации, в том числе фотографий ребенка, в научных исследованиях и публикациях. Диагноз был поставлен на основании патологоанатомического исследования материала после открытой биопсии опухоли, а также подтвержден референсом гистологических препаратов в Международном регистре ППБ (Миннеаполис, США). По данным компьютерной томографии органов грудной клетки с внутривенным контрастным усилением опухоль описывалась как образование, состоящее из разнокалиберных кистозных полостей, накапливающих по периферии контрастный препарат, и солидного компонента. Специфическая комбинированная терапия основывалась на рекомендациях Международного регистра ППБ и включала в себя полихимиотерапию по схеме IVADo/IVA и локальный контроль в объеме хирургического лечения. В настоящее время специфическая терапия завершена, пациент жив без признаков заболевания, длительность наблюдения составила 20 мес. В семейном анамнезе обращало на себя внимание наличие сиблинга (старший брат), у которого в возрасте 1 года 4 месяцев была диагностирована кистозная нефрома. По данным молекулярно-генетического исследования ткани опухоли у пациента (ППБ) и сиблинга (кистозная нефрома) выявлены патогенные соматические варианты в гене DICER1. У обоих детей наряду с соматическими генетическими вариантами обнаружен еще один патогенный вариант, герминальный статус которого был подтвержден. Герминальный вариант в гене DICER1 был унаследован пациентами от матери. Таким образом, исследования подтвердили семейный случай DICER1-синдрома. Описанные в статье случаи указывают на то, что семьи, в которых выявлен DICER1-синдром, требуют особой тактики ведения, направленной на раннее обнаружение опухолей и неопухолевых состояний, ассоциированных с данным синдромом, у носителей патогенных аллелей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>pleuropulmonary blastoma</kwd><kwd>cystic nephroma</kwd><kwd>DICER1 syndrome</kwd><kwd>genetic counseling</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>плевропульмональная бластома</kwd><kwd>кистозная нефрома</kwd><kwd>DICER1-синдром</kwd><kwd>генетическое консультирование</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы выражают глубокую благодарность ведущему исследователю Международного регистра плевропульмональной бластомы/ регистра DICER1 Kris Ann P. Schultz (Детская больница Миннесоты, США) и профессору Louis P. Dehner (Медицинский центр Вашингтонского университета, Сент-Луис, США) за консультативную помощь и проведение референса гистологических препаратов.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Manivel J.C., Priest J.R., Watterson J., Steiner M., Woods W.G., Wick M.R., et al. Pleuropulmonary blastoma. The so-called pulmonary blastoma of childhood. Cancer. 1988; 62 (8): 1516–26. DOI:10.1002/1097-0142(19881015)62:8&lt;1516::aid-cncr2820620812&gt;3.0.co;2-3</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Dishop M.K., Kuruvilla S. Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital. Arch Pathol Lab Med 2008; 132 (7): 1079–103. DOI:10.5858/2008-132-1079-PAMLTI</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Schultz K.A.P., Williams G.M., Kamihara J., Stewart D.R., Harris A.K., Bauer A.J., et al. DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res 2018; 24 (10): 2251–61. DOI:10.1158/1078-0432.CCR-17-3089</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Schultz K.A.P., Stewart D.R., Kamihara J., Bauer A.J., Merideth M.A., Stratton P., et al. DICER1 Tumor Predisposition. 2014 Apr 24 [updated 2020 Apr 30]. In: Adam M.P., Mirzaa G.M., Pagon R.A., Wallace S.E., Bean L.J.H., Gripp K.W., Amemiya A. (eds.). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Messinger Y.H., Stewart D.R., Priest J.R., Williams G.M., Harris A.K., Schultz K.A.P., et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer 2015; 121 (2): 276–85. DOI:10.1002/cncr.29032</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Caroleo A.M., De Ioris M.A., Boccuto L., Alessi I., Del Baldo G., Cacchione A., et al. DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk. Front Oncol 2021; 10: 614541. DOI:10.3389/fonc.2020.614541</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hill D.A., Jarzembowski J.A., Priest J.R., Williams G.M., Schoettler P., Dehner L.P. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol 2008; 32 (2): 282–95. DOI:10.1097/PAS.0b013e3181484165</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Bisogno G., Brennan B., Orbach D., Stachowicz-Stencel T., Cecchetto G., Indolfi P., et al. Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. Eur J Cancer 2014; 50 (1): 178–84. DOI:10.1016/j.ejca.2013.08.015</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Priest J.R., Magnuson J., Williams G.M., Abromowitch M., Byrd R., Sprinz P., et al. Cerebral metastasis and other central nervous system complications of pleuropulmonary blastoma. Pediatr Blood Cancer 2007; 49 (3): 266–73. DOI:10.1002/pbc.20937</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bisogno G., Sarnacki S., Stachowicz-Stencel T., Minard Colin V., Ferrari A., Godzinski J., et al. Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer 2021; 68 Suppl 4: e29045. DOI:10.1002/pbc.29045</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Sparber-Sauer M., Tagarelli A., Seitz G., Sorg B., Bien E., Bel-Ami T., et al. Children with progressive and relapsed pleuropulmonary blastoma: A European collaborative analysis. Pediatr Blood Cancer 2021; 68 (12): e29268. DOI:10.1002/pbc.29268</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Priest J.R., Watterson J., Strong L., Huff V., Woods W.G., Byrd R.L., et al. Pleuropulmonary blastoma: a marker for familial disease. J Pediatr 1996; 128 (2): 220–4. DOI:10.1016/s0022-3476(96)70393-1</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Hill D.A., Ivanovich J., Priest J.R., Gurnett C.A., Dehner L.P., Desruisseau D., et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009; 325 (5943): 965. DOI:10.1126/science.1174334</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Robertson J.C., Jorcyk C.L., Oxford J.T. DICER1 Syndrome: DICER1 Mutations in Rare Cancers. Cancers (Basel) 2018; 10 (5): 143. DOI:10.3390/cancers10050143</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Brenneman M., Field A., Yang J., Williams G., Doros L., Rossi C., et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model. F1000Res 2015; 4: 214. DOI:10.12688/f1000research.6746.2</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kim J., Amanda F., Schultz K.A.P., Hill D.A., Stewart D.R. The prevalence of DICER1 pathogenic variation in population databases. Int J Cancer 2017; 141 (10): 2030–6. DOI:10.1002/ijc.30907</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Шульц К.Э.П., Вилльямс Г.М., Качанов Д.Ю., Варфоломеева С.Р., Хилл Э.Д., Денер Л.П. и соавт. DICER1-синдром и плевропульмональная бластома: отчет Международного регистра плевропульмональной бластомы. Российский журнал детской гематологии и онкологии 2017; 4 (4): 9–19. DOI:10.17650/2311-1267-2017-4-4-13-19</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Doros L.A., Rossi C.T., Yang J., Field A., Williams G.M., Messinger Y., et al. DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol 2014; 27 (9): 1267–80. DOI:10.1038/modpathol.2013.242</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Stewart D.R., Best A.F., Williams G.M., Harney L.A., Carr A.G., Harris A.K., et al. Neoplasm Risk Among Individuals with a Pathogenic Germline Variant in DICER1. J Clin Oncol 2019; 37 (8): 668–76. DOI:10.1200/JCO.2018.78.4678</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kantor N., Wayne C., Nasr A. Symptom development in originally asymptomatic CPAM diagnosed prenatally: a systematic review. Pediatr Surg Int 2018; 34 (6): 613–20. DOI:10.1007/s00383-018-4264-y</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Feinberg A., Hall N.J., Williams G.M., Schultz K.A.P., Miniati D., Hill D.A., et al. Can congenital pulmonary airway malformation be distinguished from Type I pleuropulmonary blastoma based on clinical and radiological features? J Pediatr Surg 2016; 51 (1): 33–7. DOI:10.1016/j.jpedsurg.2015.10.019</mixed-citation></ref></ref-list></back></article>
